Skip to main content
. Author manuscript; available in PMC: 2021 May 26.
Published in final edited form as: Liver Transpl. 2020 Jan;26(1):127–140. doi: 10.1002/lt.25681

Table 2:

Defining alcohol associated hepatitis, modified from NIAAA AH clinical trial definition (Crabb et al Gastroenterology 2016)

Definition Clinical entity with rapid onset of jaundice with elevated AST in background of heavy alcohol use.
Pattern of alcohol use Heavy alcohol use for >6 months, <60 days of abstinence before onset of jaundice.
Supporting features
Biopsy steatohepatitis, cholestasis, severe fibrosis
Presentation malaise, tender hepatomegaly, decompensation
Labs Br>3, AST/ALT ratio 1.5, AST<400
Exclude Drug induced liver injury, biliary obstruction, viral hepatitis, autoimmune liver disease, Wilson disease
Spectrum AH versus acute on chronic liver failure Presence of cirrhosis
Definite Clinical and biopsy proven
Probable Clinical and exclude competing
Possible
Biopsy recommended
Clinically diagnosed but with potential confounding factors (e.g. pt denies alcohol)
Associated other diagnoses? E.g. Viral hepatitis